Serum Soluble Interleukin-2 Receptor as a Potential Biomarker for Immune-related Adverse Events

Autor: Yohei Funakoshi, Yoshihiro Kakeji, Kimihiro Yamashita, Masanori Toyoda, Hirotaka Suto, Ryo Takai, Ken-ichi Harada, Yoshiaki Nagatani, Hironobu Minami, Naomi Kiyota, Kimikazu Yakushijin, Yoshinori Imamura
Rok vydání: 2021
Předmět:
Zdroj: Anticancer Research. 41:1021-1026
ISSN: 1791-7530
0250-7005
DOI: 10.21873/anticanres.14857
Popis: Background/aim Biomarkers for immune-related adverse events (irAEs) induced by immune checkpoint inhibitors (ICIs) are required. We encountered a patient whose skin irAE fluctuated in parallel with serum soluble interleukin-2 receptor (sIL-2R). Patients and methods We examined 15 patients with cancer who received ICIs. Serum sIL-2R levels before and during ICI treatment were measured. The sIL-2R levels of preserved serum samples from another five patients who developed grade 3 irAEs were measured. Results Twelve patients showed no significant changes in sIL-2R levels during ICI treatment. Baseline serum sIL-2R levels in three patients increased beyond the normal range before the second cycle. These three patients had grade ≥2 irAEs at the second cycle treatment visit, supporting our hypothesis. Furthermore, at diagnosis of irAEs, the sIL-2R levels of all preserved samples from patients with grade 3 irAEs were significantly elevated. Conclusion Serum sIL-2R is a promising biomarker for the diagnosis of irAEs.
Databáze: OpenAIRE